NEUE BEHANDLUNG

European patent · EP3142701 · In force

Register entry

Publication number
EP3142701
Application number
EP15724354
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 11, 2015
Published
Mar 22, 2017
Granted
Jun 27, 2018
Protection ends at the latest
May 10, 2035
Next annual fee due
May 31, 2027
IPC classes
A61K 45/06 (2006.01)
A61K 31/405 (2006.01)
A61K 31/47 (2006.01)
A61K 31/517 (2006.01)
A61P 11/06 (2006.01)
Priority
GB 201408384 12.05.2014
GB 201417719 07.10.2014
PCT application
PCT/GB2015/051377 11.05.2015
PCT publication
WO2015/173551 19.11.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 24, 2026

    Holder’s address changed

    Owner
    Verona Pharma PLC, One Central Square, Cardiff, CF10 1FS, United Kingdom → VERONA PHARMA LIMITED, 120 MOORGATE, LONDON EC2M 6UR, United Kingdom

    Published in Swissreg on 24.07.2026

  2. Jun 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. Jun 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.05.2025 → 31.05.2026

    Published in Swissreg on 01.06.2025

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. Apr 4, 2024

    Agent removed

    Owner
    Verona Pharma PLC, One Central Square, Cardiff, CF10 1FS, United Kingdom (removed)
    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)
    Inventor
    ABBOTT-BANNER, Katharine, Verona Pharma PLC, 3 More London Riverside, London, Greater London SE1 2RE, United Kingdom, HANRAHAN, John, c/o McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir William Osler, Montreal, Québec H3G 1Y6, Canada, THOMAS, David, c/o McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir William Osler, Montreal, Québec H3G 1Y6, Canada (removed)
    Register addresses

    Published in Swissreg on 04.04.2024

  6. Apr 4, 2024

    Agent entered

    Register addresses
    Owner
    Verona Pharma PLC, One Central Square, Cardiff, CF10 1FS, United Kingdom
    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich
    Inventor
    ABBOTT-BANNER, Katharine, Verona Pharma PLC, 3 More London Riverside, London, Greater London SE1 2RE, United Kingdom, HANRAHAN, John, c/o McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir William Osler, Montreal, Québec H3G 1Y6, Canada, THOMAS, David, c/o McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir William Osler, Montreal, Québec H3G 1Y6, Canada

    Published in Swissreg on 04.04.2024

  7. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  8. Jun 28, 2018

    Agent entered

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern

    Published in Swissreg on 28.06.2018

1 earlier entry
  1. Jun 27, 2018

    Granted

    Published in Swissreg on 27.06.2018

Parties

Holder

Verona Pharma Limited

VERONA PHARMA LIMITED

120 MOORGATE, LONDON EC2M 6UR, GB

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

ABBOTT-BANNER, Katharine

London Greater London SE1 2RE, GB

HANRAHAN, John

Montreal Québec H3G 1Y6, CA

THOMAS, David

Montreal Québec H3G 1Y6, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.